United States Autoinjectors Market - By Type (Disposable Autoinjectors, Reusable Autoinjectors); By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies); By Route of Administration (Subcutaneous, Intramuscular); By En

United States Autoinjectors Market - By Type (Disposable Autoinjectors, Reusable Autoinjectors); By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies); By Route of Administration (Subcutaneous, Intramuscular); By End User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers, Others), Trend Analysis, Competitive Landscape & Forecast, 2019–2029

United States Autoinjector Market Size Booming to Cross USD 56 Billion by 2029

United States autoinjector market is gaining traction because of the increasing focus on treating and managing the alarming rise in the prevalence of anaphylaxis and other chronic diseases, such as rheumatoid arthritis, and the convenience of using autoinjectors.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the United States autoinjector market size at USD 16.98 billion in 2022. During the forecast period between 2023 and 2029, the United States autoinjector market size is projected to grow at an impressive CAGR of 18.7% reaching a value of USD 56.04 billion by 2029. The alarming rise in the prevalence of anaphylaxis and other chronic diseases, such as rheumatoid arthritis, as well as the convenience of using autoinjectors, are both factors contributing to the booming expansion of the autoinjector market in the United States. Autoinjectors make it simple for patients to self-administer medication at home. Furthermore, the expansion of the US autoinjector business is being aided by favorable government regulations including coverage under Medicare and Medicaid.

United States Autoinjectors Market – Overview

An autoinjector, sometimes known as an auto-injector, is a piece of medical equipment used to administer a dosage of a specific medicine. Autoinjectors are used to self-administer epinephrine to treat anaphylaxis, to ease migraine patients' urgent discomfort, and for other medical and emergency treatments. The majority of autoinjectors are disposable, spring-loaded, single-use syringes (prefilled syringes). Autoinjectors are created to be simple to use and to be administered by patients themselves or by unskilled persons. Depending on the substance loaded, the injection location may vary, however, it is commonly delivered into the buttocks or thigh.

United States Autoinjectors Market – By Therapy

Based on therapy, the United States autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. The anaphylaxis therapy segment accounts for the highest share in the United States autoinjector market owing to its high prevalence in the country. According to the data released by the Asthma and Allergy Foundation of America, it was discovered that anaphylaxis, a potentially fatal allergic response, occurs often in the US. One in fifty Americans experiences anaphylaxis. Many people think that the rate is greater. Most likely, it is closer to one in twenty.

Impact of COVID-19 on the United States Autoinjectors Market

The COVID-19 had had a positive impact on the United States autoinjector market in the long term. As the number of COVID-19 patients spiked in the hospitals and the entire healthcare system was overburdened, the patients suffering from other ailments delayed their hospital visits to prevent virus contraction. As a result, the use of autoinjectors in homecare settings to keep medical conditions under check surged, propelling the demand for autoinjectors. Furthermore, with expanding demand for various medical supplies including autoinjectors, syringes, and thermometers surged, the manufacturers significantly invested in expanding their production capacity, which is projected to boost the growth of the United States autoinjectors in the post-pandemic period.

Competitive Landscape

Major players operating in the United States autoinjectors market include Mylan N.V., Pfizer Inc., Sanofi, Boehringer Ingelheim International GmbH, Novartis Ag, AbbVie Inc., Amgen Inc., Biogen, Merck & Co., Inc, and Teva Pharmaceuticals Industries Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the United States Autoinjector Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the United States Autoinjector Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.